We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
1
1 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
N/A
No trial phase data available
Not yet recruiting
100.0%
No approval data available
- Vizgen and Hamamatsu Photonics announced a strategic partnership integrating MoxiePlex™ multiplex immunofluorescence imaging with InSituPlex® assays for streamlined biomarker detection. - The collaboration combines 9-color imaging capabilities with high throughput capacity of up to 60 slides per run, designed for high-volume laboratory applications. - Initial deployment focuses on multiplex immunofluorescence panels for non-small cell lung cancer research, with plans to expand into broader translational pathology applications. - The integrated solution aims to eliminate common barriers in multiplex assay development while facilitating the transition from research to clinical impact.
